Healthcare -
Biotechnology - NASDAQ - US
$ 489.49
2.02 %
$ 126 B
Market Cap
-237.62
P/E
VRTX - STOCK-BASED COMPENSATION
Stock-based Compensation VRTX - Vertex Pharmaceuticals Incorporated
698 M
LAST VALUE
19.24%
2 YEAR CAGR
14.14%
5 YEAR CAGR
14.68%
10 YEAR CAGR